TP53 and Miyoshi myopathy: In conclusion, we found that p53 activators such as nutlin‐3a enhanced antitumor effect of CPT‐11 in MM cells by upregulating the expression of CES2, an enzyme that converts CPT‐11 to its active metabolite SN‐38.